Literature DB >> 19089422

False-negative thyroglobulin measurement in recurrent/metastatic thyroid carcinomas.

Luca Giovanella.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089422     DOI: 10.1007/s00259-008-1005-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.

Authors:  Furio Pacini; Martin Schlumberger; Henning Dralle; Rossella Elisei; Johannes W A Smit; Wilmar Wiersinga
Journal:  Eur J Endocrinol       Date:  2006-06       Impact factor: 6.664

2.  Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.

Authors:  Luca Giovanella; Luca Ceriani; Antonella Ghelfo; Franco Keller; Andrea Sacchi; Marco Maffioli; Giuseppe Spriano
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

3.  Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients.

Authors:  Robert C Smallridge; Shon E Meek; Melissa A Morgan; Geoffrey S Gates; Thomas P Fox; Stefan Grebe; Vahab Fatourechi
Journal:  J Clin Endocrinol Metab       Date:  2006-10-31       Impact factor: 5.958

4.  Preoperative undetectable serum thyroglobulin in differentiated thyroid carcinoma: incidence, causes and management strategy.

Authors:  Luca Giovanella; Luca Ceriani; Antonella Ghelfo; Marco Maffioli; Franco Keller
Journal:  Clin Endocrinol (Oxf)       Date:  2007-06-11       Impact factor: 3.478

Review 5.  Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management.

Authors:  Luca Giovanella
Journal:  Clin Chem Lab Med       Date:  2008       Impact factor: 3.694

6.  Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans.

Authors:  Eun-Kyung Park; June-Key Chung; Il Han Lim; Do Joon Park; Dong Soo Lee; Myung Chul Lee; Bo Youn Cho
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-09-09       Impact factor: 9.236

  6 in total
  1 in total

Review 1.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.